Bioavailability study of once-daily CDT-ondansetron compared with immediate-release ondansetron

Trial Profile

Bioavailability study of once-daily CDT-ondansetron compared with immediate-release ondansetron

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Feb 2007

At a glance

  • Drugs Ondansetron (Primary)
  • Indications Nausea and vomiting
  • Focus Pharmacokinetics
  • Sponsors SCOLR Pharma
  • Most Recent Events

    • 08 Feb 2007 Status change
    • 27 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top